共 50 条
- [22] Compelling Evidence Suggesting the Codon Usage of SARS-CoV-2 Adapts to Human After the Split From RaTG13 EVOLUTIONARY BIOINFORMATICS, 2021, 17
- [24] SARS-CoV-2 has the advantage of competing the iMet–tRNAs with human hosts to allow efficient translation Molecular Genetics and Genomics, 2021, 296 : 113 - 118
- [26] Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice CELL REPORTS, 2020, 32 (03):
- [28] SARS-CoV-2 competes with host mRNAs for efficient translation by maintaining the mutations favorable for translation initiation Journal of Applied Genetics, 2022, 63 : 159 - 167